Chemistry
Global

Chemistry Experts

Doug Manion

CEO
drug development
Kleo Pharmaceuticals
United States of America

Doug Manion

Biography

Doug is CEO of Kleo Pharmaceuticals.  He has 20 years’ experience in drug development.  He was the Senior Vice President, Head of Specialty Development and Head of Japan and China R&D at BMS until October 2016.  He had leadership roles at BMS overseeing various therapeutic areas including virology, immunoscience, neurology, cardiology, metabolic diseases, genetically-defined diseases and fibrosis since joining in 2005. From 2001 to 2005, he was Vice President of Clinical Development and Medical Affairs for HIV/AIDS at GSK. He started his career at DuPont Pharmaceuticals in 1997.  He is Board Certified in Internal Medicine and completed his Fellowship in Infectious Diseases in Ottawa Canada and a clinical and bench research fellowship at Massachusetts General Hospital and Harvard Medical School.  Doug also serves on the Board of Directors of Celleron Therapeutics.

Research Interest

drug development

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 10th Europian Organic Chemistry Congress

    March 21-22, 2019 Rome, Italy

View more
Relevant Topics